Pramod Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pramod Kumar has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Amit Kumar
Department of Lab Medicine, RIMS, Ranchi, India
2 shared publications - Manoj Kumar Prasad
Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
2 shared publications S.P. Singh
2 shared publications- Shreya Singh
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India
2 shared publications - Sumit Sharma
Texas Southern University
2 shared publications Amit Kumar
Affiliation Department of Laboratory Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (2) , 248-260
Diagnostic Test Accuracy of Serum and Cerebrospinal Fluid C-Reactive Protein in Bacterial Meningitis: A Systematic Review and Meta-Analysis
Singh S, et al. Infect Chemother. 2025 Apr;57:e12. https://doi.org/10.3947/ic.2024.0139
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (2) , 248-260
Open AccessDiagnostic Test Accuracy of Serum and Cerebrospinal Fluid C-Reactive Protein in Bacterial Meningitis: A Systematic Review and Meta-Analysis
Singh S, et al. Infect Chemother. 2025 Apr;57:e12. https://doi.org/10.3947/ic.2024.0139
- Open Access
- 13 June 2023
- Published by XMLink in Infection & Chemotherapy
- Vol. 55 (2) , 264-277
An Updated Systematic Review and Meta-Analysis for the Diagnostic Test Accuracy of Ascitic Fluid Adenosine Deaminase in Tuberculous Peritonitis
Mahajan M, et al. Infect Chemother. 2023 Jun;55:e27. https://doi.org/10.3947/ic.2023.0014
- 13 June 2023
- Published by XMLink in Infection & Chemotherapy
- Vol. 55 (2) , 264-277
Open AccessAn Updated Systematic Review and Meta-Analysis for the Diagnostic Test Accuracy of Ascitic Fluid Adenosine Deaminase in Tuberculous Peritonitis
Mahajan M, et al. Infect Chemother. 2023 Jun;55:e27. https://doi.org/10.3947/ic.2023.0014
- 8 February 2023
- Published by Elsevier
- p. 141-160
Applications of damping and principles of vibration control
- 8 February 2023
- Published by Elsevier
- p. 141-160
Applications of damping and principles of vibration control
- 8 February 2023
- Published by Elsevier
- p. 45-56
Measurement of damping
- Open Access
- 9 September 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (9) , e0272840
Procalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis
Background: Coronavirus disease 2019 has emerged as a global pandemic causing millions of critical cases and deaths. Early identification of at-risk patients is crucial for planning triage and treatment strategies.Methods and findings: We performed this systematic review and meta-analysis to determine the pooled prognostic significance of procalcitonin in predicting mortality and severity in patients with COVID-19 using a robust methodology and clear clinical implications.Design: We used Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Cochrane Handbook for Systematic Reviews of Interventions guidelines. We included thirty-two prospective and retrospective cohort studies involving 13,154 patients.Results: The diagnostic odds ratio of procalcitonin for predicting mortality were estimated to be 11 (95% CI: 7 to 17) with sensitivity, specificity, and summary area under the curveof 0.83 (95% CI: 0.70 to 0.91), 0.69 (95% CI: 0.58 to 0.79), and 0.83 (95% CI: 0.79 to 0.86) respectively. While for identifying severe cases of COVID-19, the odds ratio was 8.0 (95% CI 5.0 to 12.0) with sensitivity, specificity, and summary area under the curve of 0.73 (95% CI 0.67 to 0.78), 0.74 (0.66 to 0.81), and 0.78 (95% CI 0.74 to 0.82) respectively.Conclusion: Procalcitonin has good discriminatory power for predicting mortality and disease severity in COVID-19 patients. Therefore, procalcitonin measurement may help identify potentially severe cases and thus decrease mortality by offering early aggressive treatment.
- 9 September 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (9) , e0272840
Open AccessProcalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis
Background: Coronavirus disease 2019 has emerged as a global pandemic causing millions of critical cases and deaths. Early identification of at-risk patients is crucial for planning triage and treatment strategies.Methods and findings: We performed this systematic review and meta-analysis to determine the pooled prognostic significance of procalcitonin in predicting mortality and severity in patients with COVID-19 using a robust methodology and clear clinical implications.Design: We used Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Cochrane Handbook for Systematic Reviews of Interventions guidelines. We included thirty-two prospective and retrospective cohort studies involving 13,154 patients.Results: The diagnostic odds ratio of procalcitonin for predicting mortality were estimated to be 11 (95% CI: 7 to 17) with sensitivity, specificity, and summary area under the curveof 0.83 (95% CI: 0.70 to 0.91), 0.69 (95% CI: 0.58 to 0.79), and 0.83 (95% CI: 0.79 to 0.86) respectively. While for identifying severe cases of COVID-19, the odds ratio was 8.0 (95% CI 5.0 to 12.0) with sensitivity, specificity, and summary area under the curve of 0.73 (95% CI 0.67 to 0.78), 0.74 (0.66 to 0.81), and 0.78 (95% CI 0.74 to 0.82) respectively.Conclusion: Procalcitonin has good discriminatory power for predicting mortality and disease severity in COVID-19 patients. Therefore, procalcitonin measurement may help identify potentially severe cases and thus decrease mortality by offering early aggressive treatment.
- 2 June 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
AI layer reference generator engine for early enablement of workloads over multiple frameworks
Compute operators/kernels (like Convolution, Relu, Gemm etc.) form the backbone of Deep Neural Network (DNN) models. With the advent of AI accelerators, there is a need to have specialized and optimized kernels for these operators to take full advantage of the features provided by the hardware. Kernels are mostly developed at High level languages like C, C++. They should work with almost the same accuracy and functionality as they would work on CPU/GPU machine. There are various ways listed below to check kernel accuracy and functionality. One of the common ways is to use Python interface provided by the different AI/ML frameworks. However, there are certain disadvantages like script level exposure which requires full stack integration and lack of multithreading because of python global interpreter lock. Another way is to develop a reference generator engine based on understanding of operators from frameworks. This strategy requires validating the correctness of the reference generator engine itself. Also, the generated reference could be at times in incompatible format and gets difficult to consume in the kernel validation code. In this paper we propose PyTeNet++ which stands for AI framework Pytorch[1], TensorFlow[2], Mxnet[3] using C++ APIs. The proposed solution is one of its kind and no such reference generator framework exists at the high-level language utilizing listed frameworks as backends. PyTeNet++ sits on top of C++ APIs exposed by these frameworks and helps to generate reference which could be seamlessly integrated with the kernel development/validation stack of the operators. It also helps to achieve maturity while kernel development. It exploits various benefits C++ provides like multithreading, low latency, high performance and OpenMP[4]. All these features are useful for faster kernel maturity. The smarter way of doing validation close to development environment helps in the early enablement (without full stack integration) of the DNN models, leading to quick maturity of the product and improved time-to-market.
- 2 June 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
AI layer reference generator engine for early enablement of workloads over multiple frameworks
Compute operators/kernels (like Convolution, Relu, Gemm etc.) form the backbone of Deep Neural Network (DNN) models. With the advent of AI accelerators, there is a need to have specialized and optimized kernels for these operators to take full advantage of the features provided by the hardware. Kernels are mostly developed at High level languages like C, C++. They should work with almost the same accuracy and functionality as they would work on CPU/GPU machine. There are various ways listed below to check kernel accuracy and functionality. One of the common ways is to use Python interface provided by the different AI/ML frameworks. However, there are certain disadvantages like script level exposure which requires full stack integration and lack of multithreading because of python global interpreter lock. Another way is to develop a reference generator engine based on understanding of operators from frameworks. This strategy requires validating the correctness of the reference generator engine itself. Also, the generated reference could be at times in incompatible format and gets difficult to consume in the kernel validation code. In this paper we propose PyTeNet++ which stands for AI framework Pytorch[1], TensorFlow[2], Mxnet[3] using C++ APIs. The proposed solution is one of its kind and no such reference generator framework exists at the high-level language utilizing listed frameworks as backends. PyTeNet++ sits on top of C++ APIs exposed by these frameworks and helps to generate reference which could be seamlessly integrated with the kernel development/validation stack of the operators. It also helps to achieve maturity while kernel development. It exploits various benefits C++ provides like multithreading, low latency, high performance and OpenMP[4]. All these features are useful for faster kernel maturity. The smarter way of doing validation close to development environment helps in the early enablement (without full stack integration) of the DNN models, leading to quick maturity of the product and improved time-to-market.